Cernostics
Pittsburgh, US · Delaware corporation · 1 known investors
Founders & leadership
MH
Michael HoerresExecutive
Board
JP
James PetersBoard director
SG
Steve GrenfellBoard director
PS
Paul SchmittBoard director
ND
Noel DohenyBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$11.7M disclosed across 4 rounds · 2015–2021
▶$6MraisedAug 2021 · 4 investors · BiotechnologyRule 506(b)
▶$6MraisedAug 2021 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael J. HoerresExecutive Officer, Director
- Tom WilliDirector
- Noel DohenyDirector
- Gregg FergusDirector
- Offering amount
- $12.5M
- Amount sold
- $6M
- Minimum investment
- $118.9K
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.5MraisedMar 2018 · 1 investors · BiotechnologyRule 506(b)
▶$2.5MraisedMar 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Courtland LongestDirector
- Michael HoerresExecutive Officer, Director
- Noel DohenyDirector
- Paul SchmittDirector
- LeRoy MetzDirector
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.3MraisedAug 2016 · 2 investors · BiotechnologyRule 506(b)
▶$1.3MraisedAug 2016 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Noel DohenyDirector
- LeRoy MetzDirector
- Michael HoerresExecutive Officer, Director
- Paul SchmittDirector
- Offering amount
- $5M
- Amount sold
- $1.3M
- First sale
- Aug 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2MraisedJun 2015 · 7 investors · BiotechnologyRule 506(b)
▶$2MraisedJun 2015 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Noel DohenyDirector
- Michael HoerresExecutive Officer, Director
- James PetersDirector
- Steve GrenfellDirector
- Paul SchmittDirector
- Offering amount
- $3.7M
- Amount sold
- $2M
- First sale
- May 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2015 | $1.2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2009 | $147.3K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- Who are Cernostics's investors?
- Cernostics's investors include Illumina Ventures.
- How much funding has Cernostics raised?
- Cernostics has disclosed $11.7M raised across 4 rounds.
- Where is Cernostics headquartered?
- Cernostics is headquartered in Pittsburgh, US.